NEW YORK--(BUSINESS WIRE)--COTA, a leader in real-world data (RWD) and analytics for oncology, today announced a strategic collaboration with Sanofi to use RWD and artificial intelligence (AI) to increase the speed of oncology trials, including for multiple myeloma. The partnership will be valuable to understand clinical outcomes that may ultimately be beneficial for patients living with cancer..

纽约--（商业新闻短讯）--COTA是肿瘤学真实世界数据（RWD）和分析领域的领导者，今天宣布与赛诺菲进行战略合作，使用RWD和人工智能（AI）来提高肿瘤学试验的速度，包括多发性骨髓瘤。这种伙伴关系对于了解最终可能对癌症患者有益的临床结果将是有价值的。。

COTA’s RWD offers critical insights into effective cancer treatment pathways and will provide valuable context on key patient populations.

COTA的RWD为有效的癌症治疗途径提供了重要的见解，并将为关键患者群体提供有价值的背景。

“Our collaboration with Sanofi has the potential to enable more patients and their families to benefit from breakthrough treatments in an expedited time frame,” said Dr. C.K. Wang, an oncologist and COTA’s chief medical officer. “We are providing high-quality RWD enabled by new AI-based tools to accelerate pharmaceutical research and improve patient care.”.

“我们与赛诺菲的合作有可能使更多患者及其家属在更快的时间内受益于突破性治疗，”COTA首席医疗官、肿瘤学家C.K.Wang博士说。“我们通过基于人工智能的新工具提供高质量的RWD，以加速药物研究并改善患者护理。”。

The project will focus on a series of questions pertinent and relevant to multiple myeloma seeking to develop a deeper understanding of the increasingly complex treatment landscape of the disease. Potential results of this partnership could impact and guide future clinical study designs as well as inform the interpretation of results of ongoing and future trials within the context of the current standard of care for multiple myeloma patients..

该项目将重点关注一系列与多发性骨髓瘤相关的问题，以寻求对该疾病日益复杂的治疗前景有更深入的了解。这种伙伴关系的潜在结果可能会影响和指导未来的临床研究设计，并在当前多发性骨髓瘤患者护理标准的背景下，为正在进行的和未来的试验结果的解释提供信息。。

About COTA, Inc.

关于COTA，Inc。

Founded by oncologists, COTA is committed to creating a precise, patient-first approach to cancer care through the use of real-world data. The company leverages technology-supported data abstraction methods to make sense of complex, fragmented patient data from the real world. Offering the highest quality oncology real-world data from leading academic and community-based cancer centers and an advanced analytics platform, COTA partners with leading life sciences companies, providers, and payers to ensure that everyone touched by cancer has a clear path to the right care.

COTA由肿瘤学家创立，致力于通过使用现实世界的数据，创建一种精确的，以患者为中心的癌症护理方法。该公司利用技术支持的数据抽象方法来理解现实世界中复杂、零散的患者数据。COTA从领先的学术和社区癌症中心提供最高质量的肿瘤学真实世界数据，并提供先进的分析平台，与领先的生命科学公司，提供商和付款人合作，以确保每个接触癌症的人都有一条明确的正确护理之路。

To learn more about COTA and how to fast-track improvements in cancer care and treatment with comprehensive and diverse real-world data and analytics, visit cotahealthcare.com..

要了解有关COTA的更多信息，以及如何利用全面多样的现实数据和分析快速改进癌症护理和治疗，请访问cotahealthcare.com。。